Clinical Trial Update: Antiischemic Effects of Empagliflozin in Diabetic Patients With Refractory Angina [Phase 4]

View source ↗

Summary

Phase 4 trial updating on antiischemic effects of empagliflozin in diabetic patients with refractory angina.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Angina
• Diabetes Mellitus

Drugs mentioned

• Empagliflozin (empagliflozin)

Snippet

Sponsor: Isfahan University of Medical Sciences | Conditions: Diabetes Mellitus | Phase 4 | Status: COMPLETED